The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
diflunisal
A difluorophenyl derivate of salicylic acid and a nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic and anti-inflammatory properties. Diflunisal competitively inhibits both cyclooxygenase (COX) -1 and -2, with higher affinity for COX-1, and subsequently blocks the conversion of arachidonic acid to prostaglandin precursors. This leads to an inhibition of the formation of prostaglandins that are involved in pain, inflammation and fever. Diflunisal differs from other salicylates, in that it is not metabolized to salicylic acid, hence it has a longer half-life. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Dolobid | |
| |||
| Foreign brand names: | | Apo-Diflunisal Flovacil Novo-Diflunisal Nu-Diflunisal | |
| |||
| Chemical structures: | | (1,1'-biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy- 2',4'-difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid | |
| |||
